Nordic ListingsIssuer Report
Ambu A/S: Quarterly Trading Report 2025 Q1
Ambu A/S: Quarterly Trading Report 2025 Q1https://view.news.eu.nasdaq.com/view?id=b8915927391fe0a0d3c8a70f75c88bd4c&lang=en&src=omxlink
Ambu A/S: Quarterly Trading Report 2025 Q1
Watch Ambu's latest callAmbu (Copenhagen:AMBU B) Q3 2026 Earnings Call · Replay · Aug 26Read the transcript of Ambu (Copenhagen:AMBU B) Q3 2026 Earnings CallEarlier from Ambu
- AMBU_B: Strong Q2 growth and margin, guidance reaffirmed amid tariff and currency headwinds
- AMBU_B: Strong Q1 growth and margin expansion led to upgraded guidance and robust outlook
- AMBU_B: Raised guidance after strong Q1; endoscopy leads growth with new launches and operational gains
- AMBU_B: Strong revenue and margin growth in FY 2023/24, with robust outlook for 2024/25
- AMBU_B: Q3 saw 15% organic growth, margin gains, and strong cash flow, with upgraded full-year guidance
Later from Ambu
- Ambu A/S: Annual Trading Report 2024
- Ambu Obtains FDA Clearance For Single-Use Flexible Cysto-Nephroscopy Solution
- Ambu rises as FDA issues import alerts on rival devices
- Ambu A/S: Quarterly Trading Report 2025 Q2
- Ambu A/S: Quarterly Trading Report 2024 Q4
Follow Ambu into a list and get an email when it puts out news.
Follow Ambu